Researchers Developed High-Throughput Proteomics Platform
A new nanoLC-MS system enables the rapid identification of thousands of proteins from single cells.
Updated on Sept. 23, 2026 in Biotech
Scientists have created a multicolumn nanoLC-MS platform that significantly accelerates single-cell proteomics analysis. The system allows for the identification of over 5,000 proteins in a single cell.
Why it matters
Conventional proteomics workflows have long been limited by low throughput and lengthy gradient requirements. This advancement removes these barriers, enabling researchers to process significantly more biological samples in less time.
The platform utilizes a 100 nL/min flow rate with 5-minute separation windows to identify up to 5,100 proteins per 250 pg injection. It maintains stable performance across 1,200 consecutive injections.
The players
HeLa
This is a widely used immortal cell line in scientific research that was used as a benchmark for protein identification in the study.
The details
The platform employs a multicolumn approach with 100% duty cycles to maximize efficiency. During the study, researchers analyzed more than 4,000 samples, including 783 LPS-treated RAW264.7 macrophages and multiple HeLa cells.
Timeline
The findings were published on September 23, 2026.
The Big Picture
This development represents a shift toward high-throughput analytical techniques that replace legacy, low-efficiency mass spectrometry workflows. It provides a new tool for deep proteome coverage that bridges the gap between single-cell resolution and large-scale data sets.
This technology provides researchers with a more efficient tool to understand cellular functions at a granular level. The increased throughput may ultimately lead to faster development cycles for new medical treatments and diagnostic tools.
The takeaway
This platform demonstrates that mass spectrometry can achieve both high speed and high protein identification depth in single cells. Researchers can now utilize these parameters to conduct more extensive studies with higher statistical confidence.
Further reading
Learn more about the latest advancements in Biotech.
Source note: This article includes information reported by Nature.
